Patient Blood Management Global Market Analysis, Trends, Growth, Research And Forecast 2033

The patient blood management market size has grown strongly in recent years. It will grow from $13.83 billion in 2023 to $14.86 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing number of surgical procedures, government initiatives, increasing demand for bloodless surgery, rising availability of blood substitutes, rising demand for quality healthcare.

The patient blood management market size is expected to see strongly grown in the next few years. It will grow to $19.07 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to aging population, growing demand for blood, changing demographics, increasing focus on personalized medicine, growing demand for safe and effective blood transfusions, increasing healthcare spending. Major trends in the forecast period include patient-centered care, data-driven decision-making, hemoglobin optimization, collaborative care, expanded use of autologous blood.

Market Overview -
Patient blood management is a patient-focused, evidence-based, and systematic approach to optimize care of patients, who might need a blood transfusion, by optimizing patients' blood, minimizing surgical blood loss, and harnessing the patient-specific physiological reserve of anemia thereby reducing the need for allogeneic blood transfusions.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=3240&type=smp

Global Patient Blood Management Market Thrives On The Rising Demand From Accidents, Trauma, And Surgical Procedures
The rising number of accidents, trauma cases, and surgical procedures contributed to the growth of the global patient blood management market. According to WHO, 1.35 million people die every year due to road accidents, and low-income and middle-income countries account for 93% of the fatalities occurring in the world due to road accidents. According to the Centers for Disease Control and Prevention, in 2021, the cesarean birth rate was 32.1% of all births. Increased number of accidents, trauma cases, and surgical procedures resulted in increased demand for blood, and its products are driving the market.

Competitive Landscape -
Major companies operating in the patient blood management market include Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMérieux SA, Asahi Kasei Corporation, KANEKA CORPORATION, Bio-Rad Laboratories Inc, Abbott Laboratories, Grifols, Roche, LIVANOVA PLC, Danaher, Mediware information systems, Kawasumi Laboratories, Haier Biomedical, Diatron MI Zrt., BAG Diagnostics GmbH, Hitachi Ltd., Ortho Clinical Diagnostics, Beckman Coulter Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., Sysmex Corporation, Nihon Kohden Corporation, Radiometer Medical ApS, Instrumentation Laboratory, F. Hoffmann-La Roche Ltd, Grifols Diagnostic Solutions Inc., HemoCue AB, Immucor GTI Diagnostics

Hemasavr Is Enhancing Blood Collection And Transfusion Efficiency In Surgical Procedures
HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss. Clinicians can economically collect sterile, anticoagulated blood without any need for specialized resources. By this, the upfront shed blood collection cost decreases, and allogenic transfusions can be avoided with improved outcomes such as decreased patient mortality, low incidence of infections, and reduced risk of multi-organ failure.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Key Segments -

The patient blood management market covered in this report is segmented -

1) By Product: Instruments, Accessories, Reagents And Kits, Softwares
2) By Component: Plasma, Whole Blood, Red Blood Cells
3) By Application: Hospital, Clinic, Other Applications

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.